Big Pharma Makes a Bold $7 Billion Bet on a New Cancer Treatment

Pharmaceutical giant Eli Lilly just dropped $3. 25 billion upfront on a startup called Kelonia Therapeutics, with the potential to pay $7 billion total if everything goes right. The big idea? A treatment that turns your own immune cells into cancer fighters without the usual lab work. Instead of yan